J Lipid Atheroscler.
2024 Sep;13(3):262-279. 10.12997/jla.2024.13.3.262.
Emerging Circulating Biomarkers for Enhanced Cardiovascular Risk Prediction
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- KMID: 2559852
- DOI: http://doi.org/10.12997/jla.2024.13.3.262
Abstract
- Cardiovascular disease (CVD) continues to be the primary cause of mortality worldwide, underscoring the importance of identifying additional cardiovascular risk factors. The consensus is that lipid levels alone do not fully reflect the status of atherosclerosis, thus necessitating extensive research on cardiovascular biomarkers. This review encompasses a wide spectrum of methodologies for identifying novel risk factors or biomarkers for CVD. Inflammation, oxidative stress, plaque instability, cardiac remodeling, and fibrosis play pivotal roles in CVD pathogenesis. We introduce and discuss several promising biomarkers—namely, osteocalcin, angiogenin, lipoprotein-associated phospholipase A2, growth differentiation factor 15, galectin-3, growth stimulation expressed gene 2, and microRNAs, all of which have potential implications in the assessment and management of cardiovascular risk.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Utility of Novel Biomarkers in the Prediction of Coronary Heart Disease
- Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures
- The utility of biomarker risk prediction score in patients with chronic heart failure
- Clinical Utility of Fluid Biomarker in Depressive Disorder
- Statistics and Deep Belief Network-Based Cardiovascular Risk Prediction
